Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


O. B. Ustinnikova has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Excipients in biological medicinal products: Functional classification, stability issues, and analytical quantitation approaches

    by A. S. Minero, O. B. Rounova, I. M. Shcherbachenko, O. B. Ustinnikova

    INTRODUCTION. When developing and evaluating new biological products (BP), potential adverse action and complicated analytical procedure are a specific issue. Innovative analytical methods and selection of excipients allow for risk minimisation and enhanced quality control of biological products.AIM. This study aimed to analyse modern quantitative approaches to BP excipients and assess their prospects in improving laboratory expertise during authorisation and quality compliance testing of a biological product that has been launched into the commercial market.DISCUSSION. The literature search was performed using SciFinder, PubMed, and eLIBRARY.RU databases. The authors showed data on functional classification of the excipients. Potential adverse effects were analysed, including sucrose nephropathy when using intravenous immunoglobulin preparations containing sucrose; hypoglycaemia; changes in amino acid metabolism; decreased DNA and RNA synthesis, and inhibition of platelet function caused by elevated sodium caprylate in albumin preparations. Analysed methods are based on excipient degradation. Possible solutions have been described (reduction or replacement with another excipient, such as sodium caprylate excluded from the BPs of many manufacturers). Innovative search approaches were used for new adjuvants (MF59, АS01, АS03, AS04, and RC-529) combining immune response inducers and delivery systems. The described mathematical model was used to select excipient composition. The authors analysed literature covering analytical methods for excipient quantitation, including liquid and gas-liquid chromatography and spectrophotometric quantitation methods of the most significant excipients in BPs (amino acids, polysorbates, phenol, phenoxyethanol, benzyl alcohol, and sodium caprylate). Prospects of different analytical techniques were considered (size-exclusion HPLC for evaluation of polysorbate 80, HILIC HPLC for selective quantitation of amino acid components, hydrophilic HPLC with refractometric detection and ion-exchange HPLC with amperometric detection for selective quantitation of carbohydrate stabilisers (sorbitol, mannitol, trehalose, glucose, lactose, sucrose, maltose), as well as gas-liquid chromatography for 2-phenoxyethanol and m-cresol.CONCLUSIONS. Selecting BP excipients is a complex task that requires a control strategy not only for established concentrations, but also for products of possible degradation. Developing unified analytical methods for excipient quantitation is a priority for quality assurance of BPs authorised and launched into the commercial market.


  • Open Access

    Certified Reference Material for Quantitative Evaluation of Carbohydrate Stabilizers by Ion Exchange HPLC

    by A. S. Minero, O. B. Rounova, O. V. Fadeikina, R. A. Volkova, O. B. Ustinnikova

    Quantitative determination of excipients is a pharmacopoeial requirement for assessing the quality of biological medicinal products. For determination of carbohydrate stabilizers (sorbitol, mannitol, trehalose, glucose, lactose, sucrose, and maltose), the Scientific Center for Expert Evaluation of Medical Products of the Ministry of Health of the Russian Federations prescribes the method of anionic exchange HPLC with pulse amperometric detection. Routine application of this method requires a reference material of in tralaboratory analytical control, since the suitability of chromatographic systems must be checked prior to use of all chromatographic methods for quality control of pharmaceutical substances and medicinal prod ucts. In addition, certified reference materials permit interlaboratory comparison of test results. In this study, we set out to develop the composition and a release form of a certified reference material for stability con trol of determination of carbohydrate stabilizers. The range of the resolution factor between the peak pairs of sorbitol/mannitol and mannitol/trehalose was used as a certified characteristic, being1.8–2.4 and 2.1–2.9, respectively. For other peak pairs (trehalose/glucose, glucose/lactose, lactose/sucrose, and sucrose/maltose), a semi-quantitative certified characteristic was assigned, i.e., a resolution factor of at least 3.0.


  • Open Access

    Issues of Physicochemical Quality Assessment of Immunobiological Medicinal Products in the Context of Formation of a Regulatory System in the Eurasian Economic Union

    by O. B. Ustinnikova, I. M. Shcherbachenko, O. N. Kolesnikova, D. D. Makarishcheva, Ju. E. Isakina, O. B. Rounova

    In this study, we consider problematic issues associated with harmonization of pharmacopoeial approaches to the assessment of the main physicochemical indicators of immunobiological medicinal products in the context of formation of a regulatory system of the Euro-Asian Economic Union (EAEU) with the purpose of ensuring the independence of the pharmaceutical market of the Russian Federation. Among the selected quality indicators of human immunoglobulin preparations, which are used in national and international pharmacopoeial standards, were selected the following: “Protein”, “Electrophoretic homogeneity”, and “Molecular parameters”. “Thiomersal”, “Phenol”, and “Aluminum” were selected to assess the quality of vaccines and anatoxins. The harmonization of the above methodological approaches to the assessment of a particular indicator is hampered by the historically evolved differences in the requirements and recommendations of the State Pharmacopoeia of the Russian Federation and the European Pharmacopoeia, recognized as the basis for the development of harmonized requirements of the EAEU pharmacopoeia. These differences relate to methodologies, standards for a particular indicator, and approaches to their metrological support (use of appropriate reference materials). In the course of the study, a comparative analysis of these differences was carried out. The tendency of most manufacturers to switch to the use of high-tech laboratory equipment based on high-performance liquid and/or gas chromatography and atomic absorption spectrometry is noted. Information on the development of these methods and the availability of appropriate reference materials is provided. The conducted comparative analysis indicates the relevance of the development and certification of pharmacopoeial reference materials for harmonized methods of determination of protein, electrophoretic homogeneity, and molecular parameters. Approaches to extending the application range of available pharmacopoeial reference materials are shown, taking into account the potential of improved methods of quality control of vaccines and anatoxins by quantitative content of preservatives and adjuvants. The Russian laboratory pharmaceutical practice is focused on the specifics of immunobiological preparations and the use of pharmacopoeial reference materials that enable intra- and inter-laboratory quality testing.


  • Разработка методики количественного определения стабилизаторов углеводной природы в биологических лекарственных препаратах на основе метода ВЭЖХ с рефрактометрическим детектированием

    by Анастасия Сальвадоровна Минеро, Ольга Борисовна Рунова, Михаил Геннадиевич Коротков, Ольга Борисовна Устинникова

    Представлены результаты разработки методики количественного определения стабилизаторов углеводной природы (сорбитола, маннитола, глюкозы, сахарозы, лактозы, мальтозы и трегалозы) в биологических лекарственных препаратах. Для анализа использовали метод ВЭЖХ с рефрактометрическим детектированием и применением в качестве подвижной фазы 75 % раствора ацетонитрила в воде. Разработанная методика специфична и линейна в диапазоне от 0,5 до 2 мг/мл. Коэффициент детерминации калибровочной кривой для сорбитола — 0,99996; маннитола — 0,99998; глюкозы — 0,99971; сахарозы — 0,99996; лактозы — 0,99994; мальтозы моногидрата — 0,99966; трегалозы дигидрата — 0,99996. Предел количественного определения составил для сорбитола 0,01 мг/мл; маннитола — 0,03 мг/мл; глюкозы — 0,05 мг/мл; сахарозы — 0,025 мг/мл; лактозы — 0,050 мг/мл; мальтозы моногидрата — 0,05 мг/мл; трегалозы дигидрата — 0,025 мг/мл. Среднее значение выявления при определении правильности находится в пределах (100 ± 5) %.


  • Open Access

    Requirements for the information on reference standards submitted in the dossier for biologicals

    by R. A. Volkova, O. V. Fadeikina, O. B. Ustinnikova, K. A. Sarkisyan, A. A. Movsesyants, V. A. Merkulov, V. V. Kosenko

    SCIENTIFIC RELEVANCE.The use of appropriately certified reference standards (RSs) is a necessary element of analytical procedure standardisation that ensures comparability of results across different laboratories assessing the quality of medicines, which is important for the quality control of biologicals. Marketing authorisation involves providing information on RSs, but no specific requirements are given for the relevant section of the dossier. Therefore, it is necessary to develop the requirements for the appropriate guidelines.AIM.This study aimed to develop specific requirements for the materials that should be included in the Reference Standards section of the dossier for a biological product.DISCUSSION.The authors analysed national and international regulatory frameworks governing RSs for biologicals, including documents by the World Health Organisation (WHO), the Eurasian Economic Union, the International Organisation for Standardisation (ISO), and the Russian Federal Agency for Technical Regulation and Metrology. Additionally, the authors analysed the experience of RS certification and use at the Scientific Centre for Expert Evaluation of Medicinal Products. This article covers specific aspects of biological RS certification, considering the differences between measurement techniques and analytical procedures. The authors formulated the key requirements for the documents submitted in the dossier section on RSs for biologicals (biological reference materials). The methods (analytical procedures) used for RS certification should be described in accordance with the requirements for standard operating procedures. Adequate validation studies should establish the necessary validation characteristics of these analytical procedures. Additionally, this article presents the requirements developed to certify primary RSs for structure confirmation of proteins in novel biologicals. The values of certified characteristics and critical quality indicators should be established, and the RS production technology should be described and in compliance with WHO recommendations and/or Good Manufacturing Practice (GMP) standards. The basic certification stages are common to all types of RSs. The RS shelf life should be established in real-time stability studies, whereas accelerated stability testing may be useful for studying degradation mechanisms and the effects of short-term deviations from the specified storage conditions. In accordance with WHO recommendations, the Reference Standards section of the registration dossier should specify changes to the RS that require regulatory approval.CONCLUSIONS.The authors believe that the requirements for the materials in the Reference Standards section of the dossier for a biological product, as systematised in this study for inclusion in the relevant guidelines, will provide a unified approach to RS development, certification, and documentation for applicants, developers, and competent authority experts and will streamline RS consideration during marketing authorisation.


  • Разработка методики количественного определения полисорбата 80 в биологических лекарственных препаратах с помощью эксклюзионной высокоэффективной жидкостной хроматографии

    by Ольга Б. Рунова, Михаил Г. Коротков, Ольга Б. Устинникова

    Разработана методика количественного определения полисорбата 80 в биологических лекарственных препаратах методом эксклюзионной высокоэффективной жидкостной хроматографии с УФ-детектированием. Для отделения белковой фракции в препаратах с высокой концентрацией белка были использованы картриджи для твердофазной экстракции OASIS HLB. Хроматографическое разделение проводили на колонке TSKgel G2000SWX в изократическом режиме. В качестве подвижной фазы использовали 0,1 М фосфатный буфер, pH 6,7, содержащий 0,1 М натрия сульфат и 0,1 % натрия додецилсульфата. Методика может быть использована для количественного определения полисорбата 80 в биологических лекарственных препаратах.


  • Open Access

    Разработка методики ионообменной ВЭЖХ для количественного определения стабилизаторов углеводной природы в биологических лекарственных препаратах

    by Анастасия Сальвадоровна Минеро, Ольга Борисовна Рунова, Михаил Геннадиевич Коротков, Ольга Борисовна Устинникова

    Представлены результаты разработки методики количественного определения стабилизаторов углеводной природы: сорбитола, маннитола, глюкозы, трегалозы, сахарозы, лактозы и мальтозы в биологических лекарственных препаратах. Для анализа использовали метод ионообменной хроматографии с импульсным амперометрическим детектированием и применением в качестве подвижной фазы раствора гидроксида натрия. Разработанная методика специфична и линейна в диапазоне от 1 до 50 мкг/мл. Коэффициент детерминации калибровочной кривой для сорбитола и сахарозы – 0,9994, для маннитола – 0,9997, для трегалозы – 0,9992, для глюкозы – 0,9998, для лактозы и мальтозы – 0,9999. Предел количественного определения составил 0,05 мкг/мл для сорбитола, маннитола, трегалозы, лактозы и сахарозы, 0,1 мкг/мл – для глюкозы и 1,0 мкг/мл – для мальтозы. Относительное стандартное отклонение концентрации сорбитола – 1,9 %, манитола – 1,5 %, трегалозы – 0,6 %, глюкозы – 0,3 %, лактозы – 1,8 %, сахарозы – 1,4 % и мальтозы – 1,7 %. Процент извлечения при определении правильности для всех испытуемых лекарственных препаратов находится в пределах (100 ± 5) %.


  • Open Access

    Quantification methods for carbohydrate compounds in biologicals: a review

    by A. S. Minero, O. B. Rounova, O. B. Ustinnikova

    Carbohydrate compounds are widely used as fillers and stabilisers in biological products. When present, these compounds guarantee that the active pharmaceutical ingredient will remain stable during production, transportation, and storage. At the same time, pharmacopoeias standardise the excipient content and require that excipients should be quantified for assessing the quality of biological products.The aim of the study was to identify promising methods for the development of quantification procedures for carbohydrate compounds in biological products.The authors analysed regulatory documents for biological products approved in the Russian Federation. The most widely used excipients, both individually and in combinations, are polyols (sorbitol and mannitol), monosaccarides (glucose), and disaccharides (trehalose, sucrose, lactose, and maltose). Using literature data, the authors reviewed the methods used for quantifying polyols, monosaccharides, and disaccharides to assess the quality of biological products. Quantitative determination of carbohydrate stabilisers employs titrimetric, spectrophotometric, enzymatic, and chromatographic methods. This review presents an analysis of the advantages and disadvantages of these methods. It highlights the advantages of ionic HPLC with amperometric detection and hydrophilic HPLC with refractometric and evaporative light scattering detection, which are sufficiently selective and can identify substances without prior derivatisation. In conclusion, ionic and hydrophilic HPLC methods are a promising base for the development of quantification procedures for carbohydrate stabilisers.


  • Open Access

    Comparability assessment of the results of thiomersal quantification in adsorbed immunobiological medicinal products by colourimetry and by cold vapor atomic absorption spectrometry

    by O. N. Kolesnikova, V. E. Tregubova, O. B. Ustinnikova, A. A. Movsesyants

    To ensure the quality of immunobiologicals, it is required to quantify the thiomersal preservative present in a number of them. The authors have previously developed an analytical procedure for thiomersal quantification in non-adsorbed immunobiological medicinal products, which is based on cold vapor atomic absorption spectrometry (CV AAS). The aim of the study was to analyse the possibility of using the CV AAS procedure for thiomersal content determination in adsorbed immunobiologicals and evaluate the comparability of thiomersal quantification results obtained by colourimetry and CV AAS. Materials and methods: the study used the national reference standard of mercury ions content and the pharmacopoeial reference standard of thiomersal content in adsorbed medicinal products (PhRS 3.1.00427), as well as samples of immunobiologicals by different manufacturers: a DTP vaccine, anatoxins, hepatitis B and influenza vaccines, and combined vaccines. The study involved CV AAS and the colourimetric reaction between mercury and dithizone. Results: the specificity of the CV AAS procedure is demonstrated by the coefficient of variation (3.95%) and the coefficient of correlation between the test sample volume and thiomersal content (0.9956). The regression analysis and the Fisher’s test value of 0.16 indicate the absence of bias. The trueness of the method is satisfactory, as the percent recovery differs from the total spiked amount by less than 10%. For the sensitivity of the CV AAS procedure, its quantification and detection limits are 6.9×10-3 μg/ mL and 2.3×10-3 μg/ mL, respectively. The Fisher’s test value obtained in the comparability assessment of the results of thiomersal quantification by colourimetry and CV AAS (1.29) is lower than the conventional tabulated one (3.96). Conclusions: according to the study, it is possible to use the CV AAS procedure for thiomersal quantification in adsorbed immunobiologicals. The established detection limit allows evaluating residual amounts of thiomersal in in-process intermediates during the production of preservative-free immunobilogical dosage forms. The comparability assessment of the results of thiomersal quantification by colourimetry and CV AAS, carried out using oneway ANOVA and Fisher’s test, showed the possibility of using PhRS 3.1.00427 to control the consistency of operation when reproducing the CV AAS procedure.


  • Open Access

    Prospects for ion chromatography in quality assessment of biologicals

    by A. S. Minero, O. B. Runova, O. B. Ustinnikova, A. A. Movsesyants

    Quantitative characterisation of excipients in biologicals is an important part of the quality assurance process both at the level of finished products and intermediates, as well as active pharmaceutical ingredients. Ion chromatography with amperometric and conductometric detection of separation products has a number of advantages. The main of the advantages is the possibility of direct determination of semivolatile compounds that have neither chromophoric groups, nor intrinsic fluorescence. The aim of this study was to compare ion chromatography with alternative methods in order to identify promising areas for its use in assessing the quality of biologicals. The authors analysed regulatory documents and literature and summarised the methods applied for quantitative determination of ionic excipients in biological medicinal products. The authors investigated the possibility of using ion chromatography for determination of the main active pharmaceutical ingredient in polysaccharide vaccines and excipients in biologicals. The study demonstrated the feasibility of ion chromatography for simultaneous quantitation of cations (ammonium, calcium, magnesium) and anions (chlorides, sulfates, nitrates) in reconstitution solvents for lyophilised biologicals; quality assessment of active pharmaceutical ingredients in biologicals (quantitative analysis of polysaccharides in polysaccharide vaccines, profiling of glycosylated proteins, etc.); and determination of several carbohydrate stabilisers in biologicals with the same analytical procedure. According to the conclusions, ion-exchange chromatography with conductometric and amperometric detection, aimed at quality assessment of biological products, can shortly take a leading position in quantitation of ionic excipients, carbohydrate stabilisers, and main active ingredients (polysaccharides) in polysaccharide vaccines, including the vaccines in the immunisation schedule.